China Universal Asset Management Company’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
AIM
AAMU
ADEF
BPC
HP
China Universal Asset Management Company's BIIB Position: Q2 2026 in Review
China Universal Asset Management Company reduced its Biogen (BIIB) stake by 9.8% in Q2 2026, selling an estimated $487K and leaving 23,497 shares worth $5.08M. The position accounts for 0.3% of the portfolio, ranked #59.
China Universal Asset Management Company first reported a position in BIIB in Q3 2022 and has held it in 16 quarters since. The position peaked at $6.95M in Q3 2024. 269 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- China Universal Asset Management Company held 23,497 shares of Biogen worth $5.08M as of Q2 2026.
- China Universal Asset Management Company sold 2,547 Biogen shares in Q2 2026, an estimated $487K.
- Biogen made up 0.3% of China Universal Asset Management Company's portfolio in Q2 2026, its #59 holding.
- China Universal Asset Management Company first reported a position in Biogen in Q3 2022 and has held it in 16 quarters since.
- China Universal Asset Management Company's Biogen position peaked at $6.95M in Q3 2024.
- 269 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.